Ali Akbar Movassaghpour

7 ta ish

Tabriz University of Medical Sciences

1. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

   Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

   MaqolaOAOchiq kirish20235 iqtibos

   ABIABI:AkademIndex/2026.other.130704

2. Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

   Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh +11

   MaqolaOAOchiq kirish20224 iqtibos

   ABIABI:AkademIndex/2026.other.130691

3. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

   Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

   Maqola20254 iqtibos

   ABIABI:AkademIndex/2026.other.826326

4. Renoprotective effects of extracellular vesicles: A systematic review

   Farzaneh Ghorbani, Ali Akbar Movassaghpour, Mehdi Talebi +2

   Sharh maqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.065546

5. Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigm

   Hossein Abbaszadeh, Farzaneh Ghorbani, Mehdi Derakhshani +2

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.065518

6. The effect of Acellularized Wharton's Jelly-derived exosomes on myeloid differentiation of umbilical cord blood-derived CD34+ hematopoietic stem cells

   Hossein Abbaszadeh, Farzaneh Ghorbani, Mehdi Derakhshani +10

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.065542

7. Regenerative potential of Wharton's jelly‐derived mesenchymal stem cells: A new horizon of stem cell therapy

   Hossein Abbaszadeh, Farzaneh Ghorbani, Mehdi Derakhshani +4

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.090364